Dabigatran  Etxilate 150 mg  ''''

Dabigatran  Etxilate 150 mg 
DABIGATREX 150 is a direct thrombin inhibitor. Thrombin is an enzyme involved in the formation of blood clots. By inhibiting thrombin, DABIGATREX 150 prevents the formation of blood clots in the arteries and veins, reducing the risk of conditions like deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke in individuals with atrial fibrillation (AFib). DABIGATREX 150 is often prescribed to individuals with non-valvular atrial fibrillation (AFib) to reduce the risk of stroke and systemic embolism. It can also be used for the treatment and prevention of DVT and PE. Common side effects of  DABIGATREX 150  may include gastrointestinal symptoms like upset stomach, abdominal pain, and gastritis.
Serious side effects can include bleeding, including gastrointestinal bleeding, and, rarely, allergic reactions. 
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now: https://www.sterisonline.com/product/dabigatrex-150-133288